QIMR’s Professor Penny Webb (right) and Dr Azam Majidi (left).Credit:QIMR
The five-year survival rate for stage three and four of the canceris just 29 per cent,making it Australia’s deadliest gynaecological cancer.
As part of the long-term study,researchers have been looking at a range of drugs to see whether any had an effect.
QIMR Berghofer’s Dr Azam Majidi chose to investigate whether regular aspirin had any benefit for the women diagnosed with the cancer,and discovered something surprising.
Loading
Of the 900 women they studied for the observational study,those who took aspirin for at least four days a week in the 12 months after diagnosis,lived longer on average than occasional or non-users.
Specifically,they lived an average of two-and-a-half months longer,which Majidi said may not sound like a lot,but is hugely significant when comparing outcomes for the deadly cancer.
“The disease is often diagnosed at an advanced stage when the prognosis is poor,and treatment options are limited,” she said.